D M Hoover|H L Thacker - JoVE Visualize

Showing results (101-110 of 112) with videos related to

Pageof 12

Sort By:

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1996

In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389J W Horn, C B Jensen, S L White, et al.

The Prostate|January 1, 1989

Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758)B L Neubauer, P Biser, C D Jones, et al.

European Journal of Human Genetics : EJHG|January 15, 1999

Phylogenetic analysis of mitochondrial DNA in Japanese pedigrees of sensorineural hearing loss associated with the A1555G mutationS Abe, S Usami, H Shinkawa, et al.

Journal of Learning Disabilities|October 27, 2004

Reading disability and chromosome 6p21.3: evaluation of MOG as a candidate geneS D Smith, P M Kelley, J W Askew, et al.

The Journal of Urology|January 1, 1986

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.

The Prostate|January 1, 1986

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1990

Comparison of in vitro and in vivo models to assess venous irritation of parenteral antibioticsD M Hoover, J B Gardner, T L Timmerman, et al.

The Prostate|October 1, 1995

Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma modelB L Neubauer, K L Best, D F Counts, et al.

The Prostate|January 1, 1993

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male ratB L Neubauer, K L Best, J A Clemens, et al.

Cancer Research|September 1, 1992

Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.

Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:

Pageof 12

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1996

In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389J W Horn, C B Jensen, S L White, et al.

The Prostate|January 1, 1989

Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758)B L Neubauer, P Biser, C D Jones, et al.

European Journal of Human Genetics : EJHG|January 15, 1999

Phylogenetic analysis of mitochondrial DNA in Japanese pedigrees of sensorineural hearing loss associated with the A1555G mutationS Abe, S Usami, H Shinkawa, et al.

Journal of Learning Disabilities|October 27, 2004

Reading disability and chromosome 6p21.3: evaluation of MOG as a candidate geneS D Smith, P M Kelley, J W Askew, et al.

The Journal of Urology|January 1, 1986

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.

The Prostate|January 1, 1986

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1990

Comparison of in vitro and in vivo models to assess venous irritation of parenteral antibioticsD M Hoover, J B Gardner, T L Timmerman, et al.

The Prostate|October 1, 1995

Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma modelB L Neubauer, K L Best, D F Counts, et al.

The Prostate|January 1, 1993

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male ratB L Neubauer, K L Best, J A Clemens, et al.

Cancer Research|September 1, 1992

Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.

Pageof 12